gene_id,uniprot_accession,gene_name,Entry.Name,Protein.names,Gene.Names,Gene.Ontology.biological.process,Gene.Ontology.IDs,PSC.56,PSC.52,PSC.54,PSC.61,PSC.64,PSC.73,PSC.76,PSC.81,PSC.59,PSC.57,PSC.69,PSC.67,PSC.71,PSC.75,PSC.78,PSC.83,PSC.0228,PSC.0187,PSC.0188,PSC.0174,PSC.0190,PSC.0231,PSC.0230,PSC.0219,PSC.0177,PSC.0186,PSC.0209,PSC.0203
g1377,P54725,RD23A_HUMAN,RD23A_HUMAN,UV excision repair protein RAD23 homolog A (HR23A) (hHR23A),RAD23A,nucleotide-excision repair [GO:0006289]; positive regulation of cell cycle [GO:0045787]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of viral genome replication [GO:0045070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434],GO:0000502; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006289; GO:0019900; GO:0031593; GO:0031648; GO:0032434; GO:0032436; GO:0032991; GO:0043130; GO:0043161; GO:0043231; GO:0045070; GO:0045787; GO:0070628; GO:1990381,2646,2007,2217,1692,3016,2484,1937,2358,3409,4954,1719,4448,3526,1230,1413,3181,3221,1352,2123,1314,1512,1541,1723,1302,1334,967,479,863
g19475,Q9H3F6,BACD3_HUMAN,BACD3_HUMAN,BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 (hBACURD3) (BTB/POZ domain-containing protein KCTD10) (Potassium channel tetramerization domain-containing protein 10),KCTD10 ULR061 MSTP028,negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005112; GO:0005654; GO:0005829; GO:0006511; GO:0016567; GO:0031463; GO:0035024; GO:0042802; GO:0043161; GO:0051260,499,525,567,480,838,747,407,516,951,1058,669,1430,1458,2823,628,4910,1558,1176,670,1012,1250,622,381,302,415,293,310,332
g9945,O73817,PSB3_ONCMY,PSB3_ONCMY,Proteasome subunit beta type-3 (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain),psmb3,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0005634; GO:0005737; GO:0005839; GO:0019774; GO:0043161,1947,1259,1247,1034,2375,1448,993,1449,2132,2676,2305,1981,2789,1344,1824,1785,1762,992,1091,1913,1151,1202,804,716,808,610,737,594
g14478,P0C2W1,FBSP1_HUMAN,FBSP1_HUMAN,F-box/SPRY domain-containing protein 1 (F-box only protein 45) (hFbxo45),FBXO45 FBX45,anterior commissure morphogenesis [GO:0021960]; cerebral cortex radially oriented cell migration [GO:0021799]; cerebral cortex tangential migration [GO:0021800]; corticospinal tract morphogenesis [GO:0021957]; DNA damage response [GO:0006974]; neuron migration [GO:0001764]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of synaptic vesicle exocytosis [GO:2000300]; synapse assembly involved in innervation [GO:0060386]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0001764; GO:0005576; GO:0005634; GO:0005737; GO:0006511; GO:0006974; GO:0014069; GO:0016567; GO:0019005; GO:0021799; GO:0021800; GO:0021957; GO:0021960; GO:0042734; GO:0042995; GO:0043161; GO:0045202; GO:0045211; GO:0060386; GO:0070936; GO:0098978; GO:0099523; GO:0099524; GO:1990756; GO:2000300,138,167,170,307,296,169,165,216,68,35,5,51,47,4,64,0,21,17,11,21,10,15,102,125,144,120,137,100
g11179,Q9R1P4,PSA1_MOUSE,PSA1_MOUSE,Proteasome subunit alpha type-1 (Macropain subunit C2) (Multicatalytic endopeptidase complex subunit C2) (Proteasome component C2) (Proteasome nu chain) (Proteasome subunit alpha-6) (alpha-6),Psma1,immune system process [GO:0002376]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0000502; GO:0001530; GO:0002376; GO:0002862; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0005839; GO:0019773; GO:0043161,3326,3126,2826,2152,2849,3325,2573,3303,2575,2968,2711,4030,4392,1189,5423,2550,1829,1109,1248,1419,708,904,1357,979,1251,1205,1218,884
g6607,Q5ZK10,NSF1C_CHICK,NSF1C_CHICK,NSFL1 cofactor p47 (p97 cofactor p47),NSFL1C RCJMB04_13o20,autophagosome assembly [GO:0000045]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of protein localization to centrosome [GO:1904780]; nuclear membrane reassembly [GO:0031468]; positive regulation of mitotic centrosome separation [GO:0046604]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0000045; GO:0000132; GO:0005634; GO:0005795; GO:0005813; GO:0005829; GO:0007030; GO:0008289; GO:0031468; GO:0043130; GO:0043161; GO:0046604; GO:0061025; GO:1904780; GO:1990730,1295,1369,902,855,1386,995,879,1226,1569,2468,1114,1958,2118,439,1580,1335,1142,525,636,499,498,650,527,365,689,530,230,405
g18476,Q8QG64,RBX1_SALSA,RBX1_SALSA,E3 ubiquitin-protein ligase RBX1 (EC 2.3.2.27) (EC 2.3.2.32) (Hyperosmotic protein 21) (sHOP21) (RING-box protein 1) (Rbx1),rbx1 hop21,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],GO:0005634; GO:0005737; GO:0006513; GO:0008270; GO:0016567; GO:0019005; GO:0031146; GO:0031463; GO:0031464; GO:0031465; GO:0031467; GO:0043161; GO:0045116; GO:0061630; GO:0061663; GO:0097602,2749,2367,2529,2191,3159,2813,1659,2393,3549,3374,3952,2790,4367,1199,5779,2525,1462,1387,1214,1135,910,1010,987,858,821,927,451,883
g21244,Q9Z2U1,PSA5_MOUSE,PSA5_MOUSE,Proteasome subunit alpha type-5 (Macropain zeta chain) (Multicatalytic endopeptidase complex zeta chain) (Proteasome subunit alpha-5) (alpha-5) (Proteasome zeta chain),Psma5,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0005634; GO:0005654; GO:0005829; GO:0005839; GO:0019773; GO:0043161,2473,1576,1212,1213,1836,1200,995,1430,2450,3437,1333,2455,3379,1076,2376,2168,3010,977,1061,1168,857,916,848,533,847,490,415,515
g14871,P25787,PSA2_HUMAN,PSA2_HUMAN,Proteasome subunit alpha type-2 (Macropain subunit C3) (Multicatalytic endopeptidase complex subunit C3) (Proteasome component C3) (Proteasome subunit alpha-2) (alpha-2),PSMA2 HC3 PSC3,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615],GO:0000502; GO:0000932; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0009615; GO:0019773; GO:0034774; GO:0043161; GO:0070062; GO:1904813,2395,1443,1562,832,1585,1222,994,1158,1611,1988,1300,2634,2454,1038,2795,2139,1710,665,889,982,620,695,731,564,610,392,812,429
g11585,P46471,PRS7_MOUSE,PRS7_MOUSE,26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2),Psmc2 Mss1,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0000932; GO:0005524; GO:0008540; GO:0016887; GO:0017025; GO:0022624; GO:0036402; GO:0043161; GO:0043197; GO:0140296,3577,2405,2803,1904,3108,2629,2129,2867,4265,5306,3317,4127,5803,2193,5992,3944,3160,1467,1626,1707,1849,1807,1248,991,1339,870,1174,921
g17328,Q9HAU4,SMUF2_HUMAN,SMUF2_HUMAN,E3 ubiquitin-protein ligase SMURF2 (hSMURF2) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase SMURF2) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2),SMURF2,"negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of trophoblast cell migration [GO:1901165]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",GO:0000122; GO:0000151; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0016567; GO:0016607; GO:0017015; GO:0030512; GO:0030514; GO:0042802; GO:0043161; GO:0045121; GO:0045892; GO:0046332; GO:0060071; GO:0061630; GO:0090263; GO:1901165,141,108,130,116,121,148,156,210,182,238,66,314,119,124,157,505,220,159,155,155,224,219,125,84,111,97,52,168
g17329,A9JRZ0,SMUF2_DANRE,SMUF2_DANRE,E3 ubiquitin-protein ligase SMURF2 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase SMURF2) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2),smurf2,negative regulation of BMP signaling pathway [GO:0030514]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],GO:0005634; GO:0005737; GO:0005886; GO:0016567; GO:0030514; GO:0043161; GO:0045121; GO:0046332; GO:0061630,309,258,266,261,342,293,357,397,316,389,141,913,321,256,336,985,713,362,416,372,683,565,284,130,173,200,108,324
g13964,P49407,ARRB1_HUMAN,ARRB1_HUMAN,Beta-arrestin-1 (Arrestin beta-1) (Non-visual arrestin-2),ARRB1 ARR1,G protein-coupled receptor internalization [GO:0002031]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601],GO:0000139; GO:0000785; GO:0001664; GO:0001934; GO:0002031; GO:0002092; GO:0003713; GO:0004857; GO:0005096; GO:0005159; GO:0005634; GO:0005654; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005905; GO:0006357; GO:0006511; GO:0007165; GO:0007601; GO:0015031; GO:0016567; GO:0016604; GO:0030659; GO:0031143; GO:0031397; GO:0031410; GO:0031625; GO:0031701; GO:0032088; GO:0032715; GO:0032717; GO:0035025; GO:0043149; GO:0043161; GO:0045746; GO:0045944; GO:0070374; GO:1990763,2153,3919,4520,3409,2708,3902,4404,3620,536,374,384,1346,929,120,298,463,572,784,467,246,206,316,2959,2135,1251,2140,1019,1643
g12733,Q8BK63,KC1A_MOUSE,KC1A_MOUSE,Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1),Csnk1a1,cell division [GO:0051301]; cell morphogenesis [GO:0000902]; Golgi organization [GO:0007030]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],GO:0000287; GO:0000776; GO:0000902; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005813; GO:0005819; GO:0005829; GO:0005929; GO:0006468; GO:0007030; GO:0007165; GO:0016055; GO:0016607; GO:0018105; GO:0030877; GO:0032436; GO:0036064; GO:0042277; GO:0043161; GO:0045104; GO:0051219; GO:0051301; GO:0090090; GO:0106310; GO:1900226; GO:1990904,1045,1386,1364,1194,1324,1288,1349,1498,1002,1538,882,2164,1547,368,689,851,744,1135,701,686,625,623,822,629,643,638,816,569
g14363,Q6GPF3,CUL3B_XENLA,CUL3B_XENLA,Cullin-3-B (CUL-3-B),cul3b,cell migration [GO:0016477]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; integrin-mediated signaling pathway [GO:0007229]; mitotic metaphase chromosome alignment [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149],GO:0000922; GO:0005634; GO:0005737; GO:0005813; GO:0005827; GO:0006513; GO:0006888; GO:0007080; GO:0007229; GO:0016477; GO:0016567; GO:0017145; GO:0031463; GO:0031625; GO:0035024; GO:0040016; GO:0043149; GO:0043161; GO:0045842; GO:0048208; GO:0072686; GO:1901992,3623,2073,2513,1749,2119,2502,2118,2246,2124,2614,1261,2987,5454,772,1011,1928,1327,1043,974,1163,874,1207,1594,1015,1020,1070,866,1071
g5001,Q5RE15,PSMD8_PONAB,PSMD8_PONAB,26S proteasome non-ATPase regulatory subunit 8 (26S proteasome regulatory subunit RPN12),PSMD8,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0005634; GO:0005829; GO:0008541; GO:0022624; GO:0043161,1391,727,977,629,1312,768,696,908,1255,1449,814,1469,1749,620,1409,995,1213,534,574,601,369,606,484,473,512,312,328,319
g5002,P62334,PRS10_MOUSE,PRS10_MOUSE,26S proteasome regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Proteasome 26S subunit ATPase 6) (Proteasome subunit p42),Psmc6 Sug2,ERAD pathway [GO:0036503]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0005524; GO:0005634; GO:0008540; GO:0016234; GO:0016887; GO:0022624; GO:0031597; GO:0036402; GO:0036503; GO:0042802; GO:0043161; GO:0045899; GO:0090261,2297,1674,1531,1139,2024,1639,1477,1736,2422,2763,1684,2205,3194,1687,1705,2906,2674,928,1107,1488,1310,1061,822,612,790,599,606,665
g5709,Q93034,CUL5_HUMAN,CUL5_HUMAN,Cullin-5 (CUL-5) (Vasopressin-activated calcium-mobilizing receptor 1) (VACM-1),CUL5 VACM1,ERBB2 signaling pathway [GO:0038128]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; reelin-mediated signaling pathway [GO:0038026]; regulation of neuron migration [GO:2001222]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],GO:0000082; GO:0004842; GO:0005262; GO:0005634; GO:0005829; GO:0016567; GO:0019005; GO:0030674; GO:0031146; GO:0031466; GO:0031625; GO:0038023; GO:0038026; GO:0038128; GO:0043161; GO:0070979; GO:0090734; GO:0097193; GO:0160072; GO:2001222,452,460,570,455,446,577,591,598,512,643,426,978,800,204,392,801,636,557,406,373,486,580,371,246,260,381,179,365
g13000,A4IF63,TRIM2_BOVIN,TRIM2_BOVIN,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2),TRIM2,negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0017148; GO:0030371; GO:0043161; GO:0043523; GO:0061630,8,15,4,0,0,6,15,0,68,29,45,228,42,8,20,11,89,106,26,2,13,10,14,0,4,3,0,19
g15362,O43242,PSMD3_HUMAN,PSMD3_HUMAN,26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58),PSMD3,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0008541; GO:0016020; GO:0022624; GO:0030234; GO:0034774; GO:0042176; GO:0043161; GO:0070062; GO:1904813,1970,1962,1786,1554,2273,1613,1706,2240,2523,3123,1981,3302,3361,1265,1541,2607,2367,1293,1359,1304,1413,1341,1389,717,1011,885,1244,761
g3209,A9JTG5,HOIL1_DANRE,HOIL1_DANRE,RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 2.3.2.31) (Heme-oxidized IRP2 ubiquitin ligase 1 homolog) (HOIL-1) (Heme-oxidized IRP2 ubiquitin transferase 1 homolog),rbck1 zgc:175152,defense response to bacterium [GO:0042742]; embryonic cranial skeleton morphogenesis [GO:0048701]; otic vesicle morphogenesis [GO:0071600]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039],GO:0004842; GO:0042742; GO:0043123; GO:0043130; GO:0043161; GO:0046872; GO:0048701; GO:0071600; GO:0071797; GO:0097039,1241,2061,2394,1314,1971,2090,2088,2448,1911,1398,1689,2513,1733,944,828,3155,2147,1319,1220,1265,1190,1758,1924,1285,1228,1299,1123,1107
g23285,Q9V3H2,PSDE_DROME,PSDE_DROME,26S proteasome non-ATPase regulatory subunit 14 (EC 3.4.19.-) (26S proteasome regulatory complex subunit p37B) (26S proteasome regulatory subunit rpn11) (Yippee-interacting protein 5),Rpn11 yip5 CG18174,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579],GO:0000502; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0008541; GO:0016579; GO:0043161; GO:0046872; GO:0070628; GO:0140492,1976,918,1267,1202,1884,1434,1216,1325,1759,2485,1734,1702,2684,852,1184,1682,1432,696,751,802,660,764,608,508,752,459,587,510
g23854,Q9R1A8,COP1_MOUSE,COP1_MOUSE,E3 ubiquitin-protein ligase COP1 (EC 2.3.2.27) (Constitutive photomorphogenesis protein 1 homolog) (mCOP1) (RING finger and WD repeat domain protein 2) (RING-type E3 ubiquitin transferase RFWD2),Cop1 Rfwd2 RNF200,positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212],GO:0000139; GO:0010212; GO:0016567; GO:0016607; GO:0031464; GO:0032436; GO:0043161; GO:0046872; GO:0061630,193,234,410,230,213,132,276,378,16,11,0,107,118,0,87,9,0,35,21,23,7,27,181,91,105,135,132,94
g23853,Q9R1A8,COP1_MOUSE,COP1_MOUSE,E3 ubiquitin-protein ligase COP1 (EC 2.3.2.27) (Constitutive photomorphogenesis protein 1 homolog) (mCOP1) (RING finger and WD repeat domain protein 2) (RING-type E3 ubiquitin transferase RFWD2),Cop1 Rfwd2 RNF200,positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212],GO:0000139; GO:0010212; GO:0016567; GO:0016607; GO:0031464; GO:0032436; GO:0043161; GO:0046872; GO:0061630,153,140,253,250,176,128,176,278,23,10,0,48,108,0,61,10,25,17,7,31,8,15,187,76,79,97,130,91
g20953,Q9V3G7,PSMD6_DROME,PSMD6_DROME,26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit S10) (Protein Rpn7),Rpn7 CG5378,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0000502; GO:0005654; GO:0005829; GO:0005838; GO:0008541; GO:0043161,2052,1747,1372,1192,1903,1596,1388,1556,1520,2177,1176,1882,2219,841,2896,1630,1779,858,967,978,673,544,890,800,936,639,726,579
g19889,A5HK05,APBP2_RAT,APBP2_RAT,Amyloid protein-binding protein 2 (Amyloid beta precursor protein-binding protein 2) (APP-BP2),Appbp2,intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],GO:0005654; GO:0005874; GO:0006886; GO:0016567; GO:0030659; GO:0031462; GO:0043161; GO:0046907; GO:1990756,580,755,927,609,757,716,723,976,908,964,477,1060,975,548,362,2893,702,421,424,350,784,613,328,185,303,428,184,340
g11649,Q9ES00,UBE4B_MOUSE,UBE4B_MOUSE,Ubiquitin conjugation factor E4 B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase E4 B) (Ubiquitin fusion degradation protein 2),Ube4b Ufd2 Ufd2a,ERAD pathway [GO:0036503]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; neuron projection development [GO:0031175]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; response to UV [GO:0009411]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular trabecula myocardium morphogenesis [GO:0003222],GO:0000151; GO:0000209; GO:0003222; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006511; GO:0006513; GO:0008626; GO:0009411; GO:0016567; GO:0019899; GO:0030163; GO:0031175; GO:0034450; GO:0034976; GO:0036503; GO:0043161; GO:0051082; GO:0051117; GO:0051865; GO:0061630,2438,1243,1297,833,1012,1106,1244,1418,1593,1228,764,2653,3863,1349,1363,5148,2198,1249,1323,1492,1523,922,2253,595,612,699,530,677
g12645,Q9P0J7,KCMF1_HUMAN,KCMF1_HUMAN,E3 ubiquitin-protein ligase KCMF1 (EC 2.3.2.27) (FGF-induced in gastric cancer) (Potassium channel modulatory factor) (PCMF) (ZZ-type zinc finger-containing protein 1),KCMF1 FIGC ZZZ1,negative regulation of HRI-mediated signaling [GO:0141191]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; response to oxidative stress [GO:0006979]; synaptic signaling [GO:0099536]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005576; GO:0005737; GO:0005764; GO:0005770; GO:0005829; GO:0005886; GO:0006511; GO:0006979; GO:0008270; GO:0043161; GO:0045202; GO:0061630; GO:0070534; GO:0070936; GO:0099536; GO:0141191; GO:1904813,655,679,564,398,656,565,564,839,712,751,299,965,887,224,589,550,436,326,306,322,283,352,498,379,319,312,254,338
g14607,Q5NVK7,SPOP_PONAB,SPOP_PONAB,Speckle-type POZ protein,SPOP,localization [GO:0051179]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of proteolysis [GO:0030162],GO:0000209; GO:0005634; GO:0005737; GO:0016607; GO:0030162; GO:0031463; GO:0031625; GO:0043161; GO:0051179,386,540,476,406,429,342,468,551,449,500,137,534,490,320,146,1007,533,324,417,252,592,429,376,260,220,331,180,166
g4190,P60901,PSA6_RAT,PSA6_RAT,Proteasome subunit alpha type-6 (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) (Proteasome subunit alpha-1) (alpha-1),Psma6,positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis involved in protein catabolic process [GO:0051603],GO:0000502; GO:0000932; GO:0003723; GO:0005634; GO:0005737; GO:0005839; GO:0005840; GO:0016363; GO:0019773; GO:0030016; GO:0030017; GO:0043161; GO:0051059; GO:0051092; GO:0051603,2567,1571,1468,1049,2250,1674,1129,1412,1704,2218,1858,2092,2942,872,2404,1898,1730,811,988,1297,604,636,790,703,660,685,642,667
g2520,Q32KL2,PSB5_BOVIN,PSB5_BOVIN,Proteasome subunit beta type-5 (EC 3.4.25.1),PSMB5,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to oxidative stress [GO:0006979],GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0005839; GO:0006979; GO:0019774; GO:0043161,3939,2973,3220,2744,4081,3284,1909,3302,3090,4307,2943,3772,4980,1240,5098,3105,2483,1052,1468,1878,1259,1063,1437,1258,1479,1014,543,1138
g16729,Q9VBP9,NPL4_DROME,NPL4_DROME,Nuclear protein localization protein 4 homolog,Npl4 CG4673,cellular response to virus [GO:0098586]; negative regulation of smoothened signaling pathway [GO:0045879]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0031625; GO:0043130; GO:0043161; GO:0045879; GO:0046872; GO:0071795; GO:0098586,199,258,356,148,347,271,319,254,467,520,180,428,374,203,318,550,431,210,141,227,230,172,199,135,146,101,131,145
g16728,P60670,NPL4_MOUSE,NPL4_MOUSE,Nuclear protein localization protein 4 homolog (Protein NPL4),Nploc4 Kiaa1499 Npl4,"ERAD pathway [GO:0036503]; Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]",GO:0005634; GO:0005783; GO:0005829; GO:0006511; GO:0007030; GO:0030970; GO:0031625; GO:0032480; GO:0034098; GO:0036501; GO:0036503; GO:0039536; GO:0042175; GO:0043130; GO:0043161; GO:0044877; GO:0046872; GO:0051117,227,226,241,104,280,153,231,229,271,445,121,311,299,128,196,402,215,128,115,262,141,143,125,76,89,60,52,50
g17771,Q969H0,FBXW7_HUMAN,FBXW7_HUMAN,F-box/WD repeat-containing protein 7 (Archipelago homolog) (hAgo) (F-box and WD-40 domain-containing protein 7) (F-box protein FBX30) (SEL-10) (hCdc4),FBXW7 FBW7 FBX30 SEL10,cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; lipid homeostasis [GO:0055088]; lung development [GO:0030324]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of osteoclast development [GO:2001205]; negative regulation of SREBP signaling pathway [GO:2000639]; negative regulation of triglyceride biosynthetic process [GO:0010868]; Notch signaling pathway [GO:0007219]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of circadian rhythm [GO:0042752]; regulation of lipid storage [GO:0010883]; regulation of mitophagy [GO:1901524]; regulation of protein localization [GO:0032880]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570],GO:0001570; GO:0001944; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006281; GO:0006974; GO:0007062; GO:0007219; GO:0010629; GO:0010868; GO:0010883; GO:0010992; GO:0016567; GO:0019005; GO:0030324; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0031648; GO:0032880; GO:0032991; GO:0034644; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045741; GO:0045746; GO:0048471; GO:0048511; GO:0050816; GO:0050821; GO:0051443; GO:0055088; GO:0070374; GO:0090049; GO:0097027; GO:1901524; GO:1901800; GO:1902806; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2000346; GO:2000639; GO:2001205,456,242,330,258,261,393,420,373,427,570,133,775,388,117,216,346,502,350,404,218,378,425,410,269,242,225,255,248
g17770,Q969H0,FBXW7_HUMAN,FBXW7_HUMAN,F-box/WD repeat-containing protein 7 (Archipelago homolog) (hAgo) (F-box and WD-40 domain-containing protein 7) (F-box protein FBX30) (SEL-10) (hCdc4),FBXW7 FBW7 FBX30 SEL10,cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; lipid homeostasis [GO:0055088]; lung development [GO:0030324]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of osteoclast development [GO:2001205]; negative regulation of SREBP signaling pathway [GO:2000639]; negative regulation of triglyceride biosynthetic process [GO:0010868]; Notch signaling pathway [GO:0007219]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of circadian rhythm [GO:0042752]; regulation of lipid storage [GO:0010883]; regulation of mitophagy [GO:1901524]; regulation of protein localization [GO:0032880]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570],GO:0001570; GO:0001944; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006281; GO:0006974; GO:0007062; GO:0007219; GO:0010629; GO:0010868; GO:0010883; GO:0010992; GO:0016567; GO:0019005; GO:0030324; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0031648; GO:0032880; GO:0032991; GO:0034644; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045741; GO:0045746; GO:0048471; GO:0048511; GO:0050816; GO:0050821; GO:0051443; GO:0055088; GO:0070374; GO:0090049; GO:0097027; GO:1901524; GO:1901800; GO:1902806; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2000346; GO:2000639; GO:2001205,176,108,126,135,149,166,126,163,215,251,75,317,182,66,111,210,246,166,120,119,186,169,152,72,87,146,144,63
g12053,Q60692,PSB6_MOUSE,PSB6_MOUSE,Proteasome subunit beta type-6 (EC 3.4.25.1) (Low molecular mass protein 19) (Macropain delta chain) (Multicatalytic endopeptidase complex delta chain) (Proteasome delta chain) (Proteasome subunit Y) (Proteasome subunit beta-1) (beta-1),Psmb6 Lmp19,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0005839; GO:0019774; GO:0043161,3479,2238,2313,1674,3974,2398,1734,2545,3137,4042,3591,3095,5449,2254,4427,3811,2795,1451,1578,1840,1336,1365,1214,1187,1169,1047,676,882
g15858,Q4R7L3,PRS6B_MACFA,PRS6B_MACFA,26S proteasome regulatory subunit 6B (26S proteasome AAA-ATPase subunit RPT3) (Proteasome 26S subunit ATPase 4),PSMC4 QtsA-14940,blastocyst development [GO:0001824]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0001824; GO:0005524; GO:0005654; GO:0005829; GO:0008540; GO:0016887; GO:0022624; GO:0036402; GO:0043161,1587,1313,1449,1175,1629,1480,1326,1578,1902,2037,1180,2222,1586,899,1342,1920,2012,990,1175,1080,867,964,1086,723,737,649,428,546
g1447,P23787,TERA_XENLA,TERA_XENLA,Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (p97) (Valosin-containing protein) (VCP),vcp,autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; interstrand cross-link repair [GO:0036297]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of protein localization to chromatin [GO:1905634]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985],GO:0000785; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006281; GO:0006302; GO:0006914; GO:0006974; GO:0008289; GO:0010494; GO:0010498; GO:0016236; GO:0016567; GO:0016887; GO:0019985; GO:0032510; GO:0034605; GO:0035617; GO:0035861; GO:0036297; GO:0036503; GO:0042802; GO:0043161; GO:0044877; GO:0061857; GO:0097352; GO:1903843; GO:1905634,12416,10573,16218,14048,22512,16997,13533,15184,24067,30267,17194,31414,29052,20966,10997,36156,23115,14364,14613,18800,20762,18543,9586,6852,9186,7080,12576,7029
g4233,P48601,PRS4_DROME,PRS4_DROME,26S proteasome regulatory subunit 4 (P26s4),Rpt2 P26s4 Pros26.4 CG5289,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0005524; GO:0005654; GO:0005829; GO:0005838; GO:0008540; GO:0016887; GO:0036402; GO:0043161,3681,3133,3107,2178,3632,2813,2317,3536,4677,6051,3443,4687,5916,2307,3045,4148,4116,1772,1712,1988,2281,2115,1683,1501,1517,969,1387,1157
g15882,Q9C040,TRIM2_HUMAN,TRIM2_HUMAN,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING finger protein 86) (RING-type E3 ubiquitin transferase TRIM2),TRIM2 KIAA0517 RNF86,negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0017148; GO:0030371; GO:0043161; GO:0043523; GO:0061630,71,30,92,48,13,22,42,46,74,49,190,114,123,47,16,111,313,751,213,23,70,292,47,27,0,15,40,25
g8525,P17439,GBA1_MOUSE,GBA1_MOUSE,Lysosomal acid glucosylceramidase (Lysosomal acid GCase) (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase) (EC 3.2.1.46) (Lysosomal glycosylceramidase),Gba1 Gba,antigen processing and presentation [GO:0019882]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; brain morphogenesis [GO:0048854]; cell maturation [GO:0048469]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; central nervous system development [GO:0007417]; ceramide biosynthetic process [GO:0046513]; cerebellar Purkinje cell layer formation [GO:0021694]; cholesterol metabolic process [GO:0008203]; determination of adult lifespan [GO:0008340]; establishment of skin barrier [GO:0061436]; glucosylceramide catabolic process [GO:0006680]; glucosylceramide metabolic process [GO:0006678]; hematopoietic stem cell proliferation [GO:0071425]; homeostasis of number of cells [GO:0048872]; lipid glycosylation [GO:0030259]; lipid storage [GO:0019915]; lymphocyte migration [GO:0072676]; lysosome organization [GO:0007040]; microglia differentiation [GO:0014004]; microglial cell proliferation [GO:0061518]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; motor behavior [GO:0061744]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of protein-containing complex assembly [GO:0031333]; nervous system process [GO:0050877]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; pyramidal neuron differentiation [GO:0021859]; regulation of membrane potential [GO:0042391]; regulation of protein metabolic process [GO:0051246]; regulation of TOR signaling [GO:0032006]; respiratory electron transport chain [GO:0022904]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin epidermis development [GO:0098773]; sphingosine biosynthetic process [GO:0046512]; T cell differentiation in thymus [GO:0033077]; termination of signal transduction [GO:0023021],GO:0000423; GO:0004336; GO:0004348; GO:0005102; GO:0005124; GO:0005615; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006678; GO:0006680; GO:0006914; GO:0007005; GO:0007040; GO:0007417; GO:0008203; GO:0008340; GO:0008422; GO:0009267; GO:0009268; GO:0014004; GO:0016787; GO:0019882; GO:0019915; GO:0021694; GO:0021859; GO:0022904; GO:0023021; GO:0030259; GO:0031333; GO:0032006; GO:0032436; GO:0032715; GO:0033077; GO:0033574; GO:0035307; GO:0042391; GO:0043161; GO:0043202; GO:0043243; GO:0043524; GO:0043627; GO:0046512; GO:0046513; GO:0046527; GO:0048469; GO:0048854; GO:0048872; GO:0050295; GO:0050877; GO:0050905; GO:0051246; GO:0051248; GO:0051402; GO:0061436; GO:0061518; GO:0061744; GO:0071356; GO:0071425; GO:0071548; GO:0072676; GO:0097066; GO:0098773; GO:1901805; GO:1903052; GO:1903061; GO:1904457; GO:1904925; GO:1905037,571,573,668,382,353,593,516,574,739,1340,249,953,1035,247,546,700,621,348,935,243,273,1047,341,375,362,242,224,225
g12673,Q3ULA2,FBW1A_MOUSE,FBW1A_MOUSE,F-box/WD repeat-containing protein 1A (Beta-TrCP protein E3RS-IkappaB) (Beta-transducin repeat-containing protein) (Beta-TrCP) (E3RSIkappaB) (mE3RS-IkappaB) (F-box and WD repeats protein beta-TrCP) (HOS) (Ubiquitin ligase FWD1) (pIkappaB-E3 receptor subunit),Btrc Fbw1 Fbxw1 Fwd1 Kiaa4123,branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of DNA-templated transcription [GO:0045892]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of proteolysis [GO:0045862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0006508; GO:0006511; GO:0008013; GO:0016055; GO:0016567; GO:0019005; GO:0030163; GO:0031146; GO:0031648; GO:0033598; GO:0038061; GO:0042752; GO:0042753; GO:0043122; GO:0043161; GO:0045309; GO:0045862; GO:0045892; GO:0045893; GO:0046983; GO:0048511; GO:0051726; GO:0060444; GO:0060828; GO:0061136; GO:0061630; GO:0070936; GO:0071407; GO:1990756; GO:1990757,899,650,615,486,700,934,768,916,1580,1593,768,2666,2020,729,601,3096,1297,1731,1745,1625,1963,1889,695,407,489,513,209,466
g6489,O88685,PRS6A_MOUSE,PRS6A_MOUSE,26S proteasome regulatory subunit 6A (26S proteasome AAA-ATPase subunit RPT5) (Proteasome 26S subunit ATPase 3) (Tat-binding protein 1) (TBP-1),Psmc3 Tbp1,blastocyst development [GO:0001824]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0000932; GO:0001824; GO:0005524; GO:0005634; GO:0008540; GO:0016887; GO:0022624; GO:0036402; GO:0043161; GO:0048471,2149,2363,2121,1546,2820,1628,1733,2362,3227,3468,1802,3054,3001,1565,1542,2462,2814,1110,1412,1629,1562,1322,1477,952,1250,1163,795,878
g3645,Q4R834,SIR2_MACFA,SIR2_MACFA,NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (NAD-dependent protein defatty-acylase sirtuin-2) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2),SIRT2 QtsA-13614,cell division [GO:0051301]; cellular lipid catabolic process [GO:0044242]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; epigenetic regulation of gene expression [GO:0040029]; myelination in peripheral nervous system [GO:0022011]; negative regulation of autophagy [GO:0010507]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; regulation of myelination [GO:0031641]; tubulin deacetylation [GO:0090042],GO:0000122; GO:0000792; GO:0003682; GO:0004407; GO:0005634; GO:0005694; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006476; GO:0010507; GO:0010801; GO:0022011; GO:0030426; GO:0030496; GO:0031641; GO:0032436; GO:0033010; GO:0033270; GO:0033558; GO:0034599; GO:0034979; GO:0034983; GO:0040029; GO:0042177; GO:0042903; GO:0043161; GO:0043204; GO:0043209; GO:0043219; GO:0043220; GO:0043388; GO:0044224; GO:0044242; GO:0045599; GO:0045836; GO:0045944; GO:0046872; GO:0046970; GO:0048471; GO:0051301; GO:0051726; GO:0051781; GO:0051987; GO:0061433; GO:0070403; GO:0070446; GO:0071456; GO:0071872; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:0140773; GO:0140774; GO:1900119; GO:1900195; GO:2000378,640,1237,1302,1019,1287,1356,1131,1258,463,508,524,511,573,148,305,244,164,182,342,160,168,296,855,881,376,631,740,582
g17977,Q9Z255,UBE2A_MOUSE,UBE2A_MOUSE,Ubiquitin-conjugating enzyme E2 A (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme A) (RAD6 homolog A) (HR6A) (mHR6A) (Ubiquitin carrier protein A) (Ubiquitin-protein ligase A),Ube2a Rad6a,blastocyst hatching [GO:0001835]; DNA repair [GO:0006281]; in utero embryonic development [GO:0001701]; maternal process involved in female pregnancy [GO:0060135]; positive regulation of mitophagy [GO:1901526]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567],GO:0000209; GO:0000785; GO:0001701; GO:0001741; GO:0001835; GO:0004842; GO:0005524; GO:0005764; GO:0005770; GO:0006281; GO:0016567; GO:0031625; GO:0033503; GO:0043161; GO:0060135; GO:0061631; GO:0070936; GO:0070979; GO:1901526,446,206,413,262,371,334,433,318,658,827,277,857,892,745,220,1444,805,565,556,807,842,582,292,221,212,151,203,250
g11907,A1Z6E0,GUS_DROME,GUS_DROME,Protein gustavus,gus CG2944,cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; wing disc morphogenesis [GO:0007472],GO:0005634; GO:0005737; GO:0005938; GO:0007281; GO:0007314; GO:0007315; GO:0007472; GO:0008104; GO:0008354; GO:0019005; GO:0031466; GO:0035017; GO:0035556; GO:0043161; GO:0045495; GO:0045732; GO:0046843; GO:0048471; GO:0070449,258,295,428,273,790,2331,406,364,9445,9611,7201,9139,7206,5455,2799,13543,6456,6323,5642,2199,6260,8969,465,360,996,538,2171,1128
g10578,Q5E9K0,PSB2_BOVIN,PSB2_BOVIN,Proteasome subunit beta type-2,PSMB2,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0005634; GO:0005654; GO:0005829; GO:0005839; GO:0019774; GO:0043161,1116,678,550,599,681,657,662,715,841,797,666,946,1215,261,1652,634,638,401,417,291,191,240,314,280,253,278,167,196
g10579,P40307,PSB2_RAT,PSB2_RAT,Proteasome subunit beta type-2 (Macropain subunit C7-I) (Multicatalytic endopeptidase complex subunit C7-I) (Proteasome component C7-I) (Proteasome subunit beta-4) (beta-4),Psmb2,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to organic cyclic compound [GO:0014070],GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0014070; GO:0019774; GO:0043161,688,472,401,365,444,431,411,564,615,480,504,742,832,259,998,484,584,284,363,250,178,246,282,235,204,233,62,190
g17254,Q80U30,CL16A_MOUSE,CL16A_MOUSE,Protein CLEC16A,Clec16a Kiaa0350,autophagy [GO:0006914]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; negative regulation of mitophagy [GO:1901525]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of autophagosome maturation [GO:1901098]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of autophagosome maturation [GO:1901096],GO:0006914; GO:0008333; GO:0016197; GO:0032435; GO:0036020; GO:0043161; GO:1901096; GO:1901098; GO:1901525,307,424,451,346,580,404,532,523,684,734,430,955,725,250,280,573,657,706,491,310,433,448,569,225,230,188,242,260
g17258,O35717,SOCS2_MOUSE,SOCS2_MOUSE,Suppressor of cytokine signaling 2 (SOCS-2),Socs2,cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; growth hormone receptor signaling pathway [GO:0060396]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of growth hormone receptor signaling pathway [GO:0060400]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of neuron differentiation [GO:0045666]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of multicellular organism growth [GO:0040014]; response to estradiol [GO:0032355],GO:0005131; GO:0005159; GO:0005737; GO:0005942; GO:0007259; GO:0007595; GO:0016567; GO:0031466; GO:0032355; GO:0035556; GO:0040014; GO:0040015; GO:0043161; GO:0045666; GO:0046426; GO:0046854; GO:0046935; GO:0060396; GO:0060400; GO:0060749; GO:0140031; GO:1990756,127,62,187,31,354,571,74,126,4788,3398,3982,6249,4914,3559,2216,12926,4311,4274,3136,1312,6449,5682,221,172,258,31,421,67
g14231,Q9UBF6,RBX2_HUMAN,RBX2_HUMAN,RING-box protein 2 (Rbx2) (EC 2.3.2.27) (EC 2.3.2.32) (CKII beta-binding protein 1) (CKBBP1) (RING finger protein 7) (Regulator of cullins 2) (Sensitive to apoptosis gene protein),RNF7 RBX2 ROC2 SAG,endoplasmic reticulum unfolded protein response [GO:0030968]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; reelin-mediated signaling pathway [GO:0038026]; regulation of neuron migration [GO:2001222]; response to redox state [GO:0051775]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005507; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0019788; GO:0030968; GO:0031466; GO:0038026; GO:0043161; GO:0043687; GO:0045116; GO:0051775; GO:0061630; GO:0061663; GO:0070979; GO:0097602; GO:2001222,1562,1215,1563,1333,1646,1691,950,1311,2335,5998,1705,2473,5534,2193,1011,4159,2152,1228,1274,1382,2750,2379,777,617,956,549,832,591
g642,Q28DT9,SPSB3_XENTR,SPSB3_XENTR,SPRY domain-containing SOCS box protein 3 (SSB-3),spsb3 TGas007f05.1,negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936],GO:0005634; GO:0010719; GO:0031466; GO:0043161; GO:0070936; GO:0160049; GO:1990756,28,31,0,3,10,19,64,51,39,80,72,393,122,3,364,66,113,180,93,11,9,57,32,23,15,32,2,54
g17367,Q6PJ21,SPSB3_HUMAN,SPSB3_HUMAN,SPRY domain-containing SOCS box protein 3 (SSB-3),SPSB3 C16orf31 SSB3,negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936],GO:0005634; GO:0005829; GO:0010719; GO:0019005; GO:0031466; GO:0043161; GO:0070936; GO:0160049; GO:1990756,246,395,458,202,322,419,323,498,4976,2323,4745,5581,5415,257,794,1469,3782,2279,2843,128,556,562,239,214,370,212,252,160
g12914,P55036,PSMD4_HUMAN,PSMD4_HUMAN,26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10) (26S proteasome regulatory subunit S5A) (Antisecretory factor 1) (AF) (ASF) (Multiubiquitin chain-binding protein),PSMD4 MCB1,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0000502; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0008540; GO:0022624; GO:0031593; GO:0042802; GO:0043161; GO:0060090,1282,1303,1354,862,1311,1321,1111,1184,1535,2161,945,1254,2143,627,1178,1109,1191,581,612,656,482,623,517,525,384,419,233,560
g12913,P55035,PSMD4_DROME,PSMD4_DROME,26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10) (26S proteasome regulatory subunit S5A) (54 kDa subunit of mu particle) (Multiubiquitin chain-binding protein) (p54),Rpn10 PROS-54 Pros54 CG7619,mitotic sister chromatid segregation [GO:0000070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0000070; GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005838; GO:0008270; GO:0008540; GO:0031593; GO:0031624; GO:0043161,1180,944,893,669,931,916,836,1019,1128,1239,912,1148,1668,619,910,968,922,459,599,548,423,476,515,339,365,432,372,374
g10308,D2GXS7,TRIM2_AILME,TRIM2_AILME,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2),TRIM2,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0030371; GO:0043161; GO:0043523; GO:0061630,336,675,782,565,439,573,834,671,100,57,32,212,47,6,399,41,23,65,52,33,15,44,359,215,187,251,300,202
g19544,Q61382,TRAF4_MOUSE,TRAF4_MOUSE,TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich motif associated to RING and Traf domains protein 1),Traf4 Cart1,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323]; signal transduction [GO:0007165],GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007165; GO:0007585; GO:0008270; GO:0016740; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0042802; GO:0042981; GO:0043122; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699,29,79,56,0,0,21,26,30,165,21,123,165,125,32,197,199,397,2043,404,30,44,113,70,34,8,17,20,31
g6193,O08759,UBE3A_MOUSE,UBE3A_MOUSE,Ubiquitin-protein ligase E3A (EC 2.3.2.26) (HECT-type ubiquitin transferase E3A) (Oncogenic protein-associated protein E6-AP),Ube3a,androgen receptor signaling pathway [GO:0030521]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; locomotory exploration behavior [GO:0035641]; modulation of chemical synaptic transmission [GO:0050804]; motor learning [GO:0061743]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of TORC1 signaling [GO:1904262]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic plasticity [GO:0048167]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000209; GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0008021; GO:0016567; GO:0030521; GO:0031398; GO:0032570; GO:0035037; GO:0035641; GO:0042220; GO:0042542; GO:0042752; GO:0043161; GO:0045944; GO:0046872; GO:0048167; GO:0048511; GO:0050804; GO:0050847; GO:0051865; GO:0051897; GO:0060736; GO:0061002; GO:0061630; GO:0061743; GO:0070936; GO:0098978; GO:0099524; GO:1904262; GO:1905528; GO:1990416; GO:2000058,1325,1076,1012,597,725,772,1068,1077,864,711,1101,1446,1815,639,1071,2032,1049,939,559,641,868,643,684,409,402,560,494,311
g10811,Q8VHQ2,SOCS7_MOUSE,SOCS7_MOUSE,Suppressor of cytokine signaling 7 (SOCS-7),Socs7 Cish7 Nap4,cerebral cortex radially oriented cell migration [GO:0021799]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; layer formation in cerebral cortex [GO:0021819]; negative regulation of signal transduction [GO:0009968]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; radial glia guided migration of Purkinje cell [GO:0021942],GO:0005634; GO:0005737; GO:0005886; GO:0005942; GO:0008286; GO:0009968; GO:0016567; GO:0021799; GO:0021819; GO:0021942; GO:0031466; GO:0035556; GO:0043161; GO:0045444; GO:0046854; GO:0046935; GO:0140031; GO:1990756,475,530,1033,344,588,1745,730,869,1327,1992,539,2123,581,598,484,1845,916,906,976,742,2474,1764,711,370,335,473,437,380
g19466,Q92890,UFD1_HUMAN,UFD1_HUMAN,Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1) (UB fusion protein 1),UFD1 UFD1L,"cellular response to misfolded protein [GO:0071218]; ERAD pathway [GO:0036503]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent protein catabolic process [GO:0006511]",GO:0001501; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0030970; GO:0031593; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0036503; GO:0039536; GO:0043161; GO:0071218,912,1218,1074,367,628,808,676,1165,872,1235,398,903,1343,357,1764,677,771,232,367,435,358,388,605,382,167,290,117,229
g20821,Q91ZT8,ASB9_MOUSE,ASB9_MOUSE,Ankyrin repeat and SOCS box protein 9 (ASB-9),Asb9,intracellular signal transduction [GO:0035556]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],GO:0005739; GO:0016567; GO:0031466; GO:0035556; GO:0043161; GO:0045732; GO:1990756,160,325,318,254,205,326,269,234,76,27,21,83,32,10,181,15,14,30,35,0,0,16,174,183,83,136,75,79
g23546,P70195,PSB7_MOUSE,PSB7_MOUSE,Proteasome subunit beta type-7 (EC 3.4.25.1) (Macropain chain Z) (Multicatalytic endopeptidase complex chain Z) (Proteasome subunit Z) (Proteasome subunit beta-2) (beta-2),Psmb7 Mmc14,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005829; GO:0005839; GO:0016604; GO:0019774; GO:0043161,5938,3549,3517,2571,4110,3917,2666,3430,3680,4860,3619,4156,6206,1076,4083,2617,2140,1608,1839,1617,1118,1215,1620,1341,1454,1304,948,1252
g8908,P25789,PSA4_HUMAN,PSA4_HUMAN,Proteasome subunit alpha type-4 (Macropain subunit C9) (Multicatalytic endopeptidase complex subunit C9) (Proteasome component C9) (Proteasome subunit L) (Proteasome subunit alpha-3) (alpha-3),PSMA4 HC9 PSC9,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0000502; GO:0000932; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0019773; GO:0043161; GO:0043231; GO:0070062,2249,1321,1384,833,2119,1229,1072,1588,1666,1297,1370,2166,2633,475,3478,1021,1634,701,1152,771,500,478,821,621,778,648,236,608
g22030,A0A0G2JZ79,SIR1_RAT,SIR1_RAT,NAD-dependent protein deacetylase sirtuin-1 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-1) (EC 2.3.1.-),Sirt1,"angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to amyloid-beta [GO:1904646]; cellular response to antibiotic [GO:0071236]; cellular response to curcumin [GO:1904644]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to organic cyclic compound [GO:0071407]; cellular response to resveratrol [GO:1904639]; cellular response to rotenone [GO:1904648]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin B3 [GO:0071303]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; DNA synthesis involved in DNA repair [GO:0000731]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; heterochromatin formation [GO:0031507]; intracellular glucose homeostasis [GO:0001678]; intracellular triglyceride homeostasis [GO:0035356]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage differentiation [GO:0030225]; maintenance of nucleus location [GO:0051658]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of triglyceride biosynthetic process [GO:0010868]; negative regulation of tumor necrosis factor production [GO:0032720]; neuron apoptotic process [GO:0051402]; ovulation from ovarian follicle [GO:0001542]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of heart rate [GO:0010460]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of thyroid-stimulating hormone secretion [GO:2000614]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein depropionylation [GO:0106230]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; rDNA heterochromatin formation [GO:0000183]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell population proliferation [GO:0042127]; regulation of centrosome duplication [GO:0010824]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of smooth muscle cell apoptotic process [GO:0034391]; regulation of transcription by glucose [GO:0046015]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to fluoride [GO:1902617]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to kainic acid [GO:1904373]; response to leptin [GO:0044321]; response to mycotoxin [GO:0010046]; response to nutrient levels [GO:0031667]; response to oxidative stress [GO:0006979]; response to resveratrol [GO:1904638]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; vasodilation [GO:0042311]; white fat cell differentiation [GO:0050872]",GO:0000012; GO:0000122; GO:0000183; GO:0000720; GO:0000731; GO:0000785; GO:0000791; GO:0000792; GO:0000978; GO:0001525; GO:0001542; GO:0001678; GO:0001934; GO:0001938; GO:0002039; GO:0002821; GO:0003713; GO:0003714; GO:0004407; GO:0005634; GO:0005635; GO:0005637; GO:0005654; GO:0005677; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006325; GO:0006642; GO:0006974; GO:0006979; GO:0007179; GO:0007283; GO:0007346; GO:0007517; GO:0007623; GO:0008284; GO:0008630; GO:0009267; GO:0010046; GO:0010460; GO:0010629; GO:0010659; GO:0010667; GO:0010824; GO:0010868; GO:0010875; GO:0010883; GO:0010906; GO:0010976; GO:0014858; GO:0016239; GO:0016567; GO:0016605; GO:0016922; GO:0017136; GO:0019213; GO:0019899; GO:0019904; GO:0030225; GO:0030424; GO:0030426; GO:0030512; GO:0031393; GO:0031507; GO:0031648; GO:0031667; GO:0032007; GO:0032041; GO:0032720; GO:0032868; GO:0032922; GO:0032991; GO:0033210; GO:0033553; GO:0033558; GO:0034391; GO:0034979; GO:0035098; GO:0035356; GO:0035358; GO:0035774; GO:0042127; GO:0042149; GO:0042220; GO:0042311; GO:0042393; GO:0042542; GO:0042595; GO:0042632; GO:0042771; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0043124; GO:0043161; GO:0043398; GO:0043422; GO:0043425; GO:0043518; GO:0043524; GO:0043536; GO:0044321; GO:0045348; GO:0045471; GO:0045599; GO:0045722; GO:0045739; GO:0045766; GO:0045786; GO:0045892; GO:0045944; GO:0046015; GO:0046628; GO:0046872; GO:0046969; GO:0046970; GO:0050872; GO:0051019; GO:0051152; GO:0051402; GO:0051658; GO:0051897; GO:0051898; GO:0055089; GO:0060125; GO:0060766; GO:0060907; GO:0061051; GO:0061773; GO:0070301; GO:0070403; GO:0070577; GO:0070857; GO:0070914; GO:0071236; GO:0071303; GO:0071356; GO:0071407; GO:0071456; GO:0071479; GO:0090312; GO:0090335; GO:0090400; GO:0097009; GO:0106230; GO:0106231; GO:0140297; GO:0140861; GO:0140937; GO:0141050; GO:0160012; GO:1900181; GO:1901797; GO:1901984; GO:1902166; GO:1902176; GO:1902237; GO:1902617; GO:1903427; GO:1904179; GO:1904373; GO:1904638; GO:1904639; GO:1904644; GO:1904646; GO:1904648; GO:1990254; GO:1990830; GO:1990841; GO:2000111; GO:2000270; GO:2000614; GO:2000655; GO:2000757; GO:2000773; GO:2000774; GO:2000781,498,353,444,424,468,369,403,527,1950,2613,774,1950,2005,499,467,1296,1552,582,813,174,920,1285,353,174,174,276,233,172
g22031,A0A0G2JZ79,SIR1_RAT,SIR1_RAT,NAD-dependent protein deacetylase sirtuin-1 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-1) (EC 2.3.1.-),Sirt1,"angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to amyloid-beta [GO:1904646]; cellular response to antibiotic [GO:0071236]; cellular response to curcumin [GO:1904644]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to organic cyclic compound [GO:0071407]; cellular response to resveratrol [GO:1904639]; cellular response to rotenone [GO:1904648]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin B3 [GO:0071303]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; DNA synthesis involved in DNA repair [GO:0000731]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; heterochromatin formation [GO:0031507]; intracellular glucose homeostasis [GO:0001678]; intracellular triglyceride homeostasis [GO:0035356]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage differentiation [GO:0030225]; maintenance of nucleus location [GO:0051658]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of triglyceride biosynthetic process [GO:0010868]; negative regulation of tumor necrosis factor production [GO:0032720]; neuron apoptotic process [GO:0051402]; ovulation from ovarian follicle [GO:0001542]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of heart rate [GO:0010460]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of thyroid-stimulating hormone secretion [GO:2000614]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein depropionylation [GO:0106230]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; rDNA heterochromatin formation [GO:0000183]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell population proliferation [GO:0042127]; regulation of centrosome duplication [GO:0010824]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of smooth muscle cell apoptotic process [GO:0034391]; regulation of transcription by glucose [GO:0046015]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to fluoride [GO:1902617]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to kainic acid [GO:1904373]; response to leptin [GO:0044321]; response to mycotoxin [GO:0010046]; response to nutrient levels [GO:0031667]; response to oxidative stress [GO:0006979]; response to resveratrol [GO:1904638]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; vasodilation [GO:0042311]; white fat cell differentiation [GO:0050872]",GO:0000012; GO:0000122; GO:0000183; GO:0000720; GO:0000731; GO:0000785; GO:0000791; GO:0000792; GO:0000978; GO:0001525; GO:0001542; GO:0001678; GO:0001934; GO:0001938; GO:0002039; GO:0002821; GO:0003713; GO:0003714; GO:0004407; GO:0005634; GO:0005635; GO:0005637; GO:0005654; GO:0005677; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006325; GO:0006642; GO:0006974; GO:0006979; GO:0007179; GO:0007283; GO:0007346; GO:0007517; GO:0007623; GO:0008284; GO:0008630; GO:0009267; GO:0010046; GO:0010460; GO:0010629; GO:0010659; GO:0010667; GO:0010824; GO:0010868; GO:0010875; GO:0010883; GO:0010906; GO:0010976; GO:0014858; GO:0016239; GO:0016567; GO:0016605; GO:0016922; GO:0017136; GO:0019213; GO:0019899; GO:0019904; GO:0030225; GO:0030424; GO:0030426; GO:0030512; GO:0031393; GO:0031507; GO:0031648; GO:0031667; GO:0032007; GO:0032041; GO:0032720; GO:0032868; GO:0032922; GO:0032991; GO:0033210; GO:0033553; GO:0033558; GO:0034391; GO:0034979; GO:0035098; GO:0035356; GO:0035358; GO:0035774; GO:0042127; GO:0042149; GO:0042220; GO:0042311; GO:0042393; GO:0042542; GO:0042595; GO:0042632; GO:0042771; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0043124; GO:0043161; GO:0043398; GO:0043422; GO:0043425; GO:0043518; GO:0043524; GO:0043536; GO:0044321; GO:0045348; GO:0045471; GO:0045599; GO:0045722; GO:0045739; GO:0045766; GO:0045786; GO:0045892; GO:0045944; GO:0046015; GO:0046628; GO:0046872; GO:0046969; GO:0046970; GO:0050872; GO:0051019; GO:0051152; GO:0051402; GO:0051658; GO:0051897; GO:0051898; GO:0055089; GO:0060125; GO:0060766; GO:0060907; GO:0061051; GO:0061773; GO:0070301; GO:0070403; GO:0070577; GO:0070857; GO:0070914; GO:0071236; GO:0071303; GO:0071356; GO:0071407; GO:0071456; GO:0071479; GO:0090312; GO:0090335; GO:0090400; GO:0097009; GO:0106230; GO:0106231; GO:0140297; GO:0140861; GO:0140937; GO:0141050; GO:0160012; GO:1900181; GO:1901797; GO:1901984; GO:1902166; GO:1902176; GO:1902237; GO:1902617; GO:1903427; GO:1904179; GO:1904373; GO:1904638; GO:1904639; GO:1904644; GO:1904646; GO:1904648; GO:1990254; GO:1990830; GO:1990841; GO:2000111; GO:2000270; GO:2000614; GO:2000655; GO:2000757; GO:2000773; GO:2000774; GO:2000781,240,138,266,155,191,224,158,268,902,1252,471,902,1009,253,244,663,982,371,380,142,582,540,160,116,147,108,82,116
g5983,Q13490,BIRC2_HUMAN,BIRC2_HUMAN,Baculoviral IAP repeat-containing protein 2 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 1) (C-IAP1) (IAP homolog B) (Inhibitor of apoptosis protein 2) (hIAP-2) (hIAP2) (RING finger protein 48) (RING-type E3 ubiquitin transferase BIRC2) (TNFR2-TRAF-signaling complex protein 2),BIRC2 API1 MIHB RNF48,"apoptotic process [GO:0006915]; canonical NF-kappaB signal transduction [GO:0007249]; cell surface receptor signaling pathway [GO:0007166]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; non-canonical NF-kappaB signal transduction [GO:0038061]; placenta development [GO:0001890]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]",GO:0000209; GO:0001666; GO:0001741; GO:0001890; GO:0003713; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0007166; GO:0007249; GO:0008270; GO:0009898; GO:0016740; GO:0031398; GO:0033209; GO:0034121; GO:0035631; GO:0038061; GO:0039535; GO:0042127; GO:0042802; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0043130; GO:0043161; GO:0044877; GO:0045088; GO:0045471; GO:0045595; GO:0050727; GO:0051087; GO:0051591; GO:0051726; GO:0060544; GO:0060546; GO:0061630; GO:0070266; GO:0070424; GO:0098770; GO:1901222; GO:1902443; GO:1902523; GO:1902524; GO:1902527; GO:2000116; GO:2000377,1001,1691,2528,1153,1695,1517,1947,2114,7914,8140,3751,10488,5564,8381,2312,20381,12393,8691,4064,3005,11900,6823,1531,833,736,1026,1241,1050
g703,Q03601,NHL1_CAEEL,NHL1_CAEEL,RING finger protein nhl-1,nhl-1 F54G8.4,negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567],GO:0000209; GO:0004842; GO:0016567; GO:0017148; GO:0030371; GO:0043161; GO:0046872; GO:0061630,697,539,1059,631,713,856,655,1126,855,584,509,1169,774,211,448,550,678,607,506,548,599,454,508,398,406,754,258,470
g15513,Q8VBV4,FBXW7_MOUSE,FBXW7_MOUSE,F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7) (F-box protein FBW7) (F-box protein Fbxw6) (F-box-WD40 repeat protein 6) (SEL-10),Fbxw7 Fbw7 Fbwd6 Fbxw6,cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; lung development [GO:0030324]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; Notch signaling pathway [GO:0007219]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein K63-linked ubiquitination [GO:0070534]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculogenesis [GO:0001570],GO:0001570; GO:0005634; GO:0005694; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0006281; GO:0006974; GO:0007062; GO:0007219; GO:0010629; GO:0010992; GO:0016020; GO:0016567; GO:0019005; GO:0030324; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0031648; GO:0034644; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045741; GO:0048471; GO:0048511; GO:0050816; GO:0050821; GO:0051443; GO:0070374; GO:0070534; GO:0090049; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2001205,240,268,295,237,206,190,314,271,47,67,61,186,146,19,68,28,33,20,18,15,1,8,155,109,86,117,218,102
g15512,D3Z902,FBXW7_RAT,FBXW7_RAT,F-box/WD repeat-containing protein 7,Fbxw7,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; lung development [GO:0030324]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; Notch signaling pathway [GO:0007219]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein K63-linked ubiquitination [GO:0070534]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculogenesis [GO:0001570],GO:0001570; GO:0005634; GO:0005694; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0006281; GO:0006974; GO:0007062; GO:0007219; GO:0010629; GO:0010992; GO:0016567; GO:0019005; GO:0030324; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0031648; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0048471; GO:0048511; GO:0050816; GO:0050821; GO:0070374; GO:0070534; GO:0090049; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2001205,207,300,420,265,303,193,319,278,57,56,37,257,132,11,58,98,40,23,17,31,28,20,201,85,65,124,86,73
g23479,P46379,BAG6_HUMAN,BAG6_HUMAN,Large proline-rich protein BAG6 (BAG family molecular chaperone regulator 6) (BCL2-associated athanogene 6) (BAG-6) (HLA-B-associated transcript 3) (Protein G3) (Protein Scythe),BAG6 BAT3 G3,apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ERAD pathway [GO:0036503]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; maintenance of unfolded protein [GO:0036506]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; positive regulation of ERAD pathway [GO:1904294]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0001822; GO:0002429; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006511; GO:0006620; GO:0006915; GO:0007130; GO:0007283; GO:0007420; GO:0010498; GO:0016020; GO:0018393; GO:0030101; GO:0030154; GO:0030324; GO:0030544; GO:0031593; GO:0031625; GO:0031647; GO:0032435; GO:0036503; GO:0036506; GO:0042771; GO:0042802; GO:0043022; GO:0043066; GO:0043161; GO:0043231; GO:0045861; GO:0045995; GO:0050821; GO:0051787; GO:0060090; GO:0061857; GO:0070059; GO:0070062; GO:0070628; GO:0071816; GO:0071818; GO:0140677; GO:1904294; GO:1990381,317,308,481,326,403,281,287,423,457,666,180,502,411,364,245,1210,463,205,275,406,496,434,194,138,198,177,124,130
g23478,P46379,BAG6_HUMAN,BAG6_HUMAN,Large proline-rich protein BAG6 (BAG family molecular chaperone regulator 6) (BCL2-associated athanogene 6) (BAG-6) (HLA-B-associated transcript 3) (Protein G3) (Protein Scythe),BAG6 BAT3 G3,apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ERAD pathway [GO:0036503]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; maintenance of unfolded protein [GO:0036506]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; positive regulation of ERAD pathway [GO:1904294]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0001822; GO:0002429; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006511; GO:0006620; GO:0006915; GO:0007130; GO:0007283; GO:0007420; GO:0010498; GO:0016020; GO:0018393; GO:0030101; GO:0030154; GO:0030324; GO:0030544; GO:0031593; GO:0031625; GO:0031647; GO:0032435; GO:0036503; GO:0036506; GO:0042771; GO:0042802; GO:0043022; GO:0043066; GO:0043161; GO:0043231; GO:0045861; GO:0045995; GO:0050821; GO:0051787; GO:0060090; GO:0061857; GO:0070059; GO:0070062; GO:0070628; GO:0071816; GO:0071818; GO:0140677; GO:1904294; GO:1990381,1268,1561,1950,1153,2049,1549,1671,1951,2420,3298,952,2448,2037,2169,1183,5794,2700,1074,1432,2661,2802,1851,1439,839,898,910,755,744
g1435,P54802,ANAG_HUMAN,ANAG_HUMAN,Alpha-N-acetylglucosaminidase (EC 3.2.1.50) (N-acetyl-alpha-glucosaminidase) (NAG) [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form; Alpha-N-acetylglucosaminidase 77 kDa form],NAGLU UFHSD1,adult behavior [GO:0030534]; amyloid precursor protein metabolic process [GO:0042982]; aorta morphogenesis [GO:0035909]; astrocyte activation [GO:0048143]; autophagy [GO:0006914]; cardiac muscle cell development [GO:0055013]; cell surface receptor signaling pathway via STAT [GO:0097696]; cellular lipid catabolic process [GO:0044242]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidative stress [GO:0034599]; cerebellar Purkinje cell layer development [GO:0021680]; collagen metabolic process [GO:0032963]; cone retinal bipolar cell differentiation [GO:1904390]; cytoplasm organization [GO:0007028]; determination of adult lifespan [GO:0008340]; endothelium development [GO:0003158]; exploration behavior [GO:0035640]; ganglioside metabolic process [GO:0001573]; Golgi organization [GO:0007030]; hair follicle morphogenesis [GO:0031069]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparan sulfate proteoglycan metabolic process [GO:0030201]; heparin metabolic process [GO:0030202]; hormone metabolic process [GO:0042445]; inner ear receptor cell development [GO:0060119]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; limb development [GO:0060173]; liver development [GO:0001889]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; maintenance of blood-brain barrier [GO:0035633]; microglia differentiation [GO:0014004]; microglial cell activation [GO:0001774]; middle ear morphogenesis [GO:0042474]; mitral valve morphogenesis [GO:0003183]; motor behavior [GO:0061744]; multicellular organismal-level iron ion homeostasis [GO:0060586]; nerve development [GO:0021675]; nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein processing [GO:0016485]; response to disaccharide [GO:0034285]; response to lipopolysaccharide [GO:0032496]; response to wounding [GO:0009611]; retinal rod cell development [GO:0046548]; rod bipolar cell differentiation [GO:1904389]; sequestering of iron ion [GO:0097577]; superoxide metabolic process [GO:0006801]; toll-like receptor 4 signaling pathway [GO:0034142]; vesicle tethering [GO:0099022],GO:0001573; GO:0001774; GO:0001889; GO:0003158; GO:0003183; GO:0003220; GO:0004561; GO:0005764; GO:0006801; GO:0006914; GO:0007028; GO:0007030; GO:0007040; GO:0007399; GO:0008340; GO:0009611; GO:0014004; GO:0016485; GO:0021675; GO:0021680; GO:0030200; GO:0030201; GO:0030202; GO:0030534; GO:0031069; GO:0032496; GO:0032963; GO:0034142; GO:0034285; GO:0034599; GO:0035633; GO:0035640; GO:0035909; GO:0042445; GO:0042474; GO:0042982; GO:0043161; GO:0043202; GO:0044242; GO:0045475; GO:0046548; GO:0048143; GO:0055013; GO:0060119; GO:0060173; GO:0060586; GO:0061744; GO:0070062; GO:0071407; GO:0097577; GO:0097696; GO:0099022; GO:1904389; GO:1904390,1871,2288,3454,3246,1708,3022,3082,2194,971,371,231,1273,783,42,1750,295,370,413,341,56,231,169,1348,1356,1474,1541,722,1249
g1579,Q5T447,HECD3_HUMAN,HECD3_HUMAN,E3 ubiquitin-protein ligase HECTD3 (EC 2.3.2.26) (HECT domain-containing protein 3) (HECT-type E3 ubiquitin transferase HECTD3),HECTD3,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],GO:0004842; GO:0016567; GO:0019905; GO:0043161; GO:0048471,1443,1171,1582,1170,1094,942,954,1091,356,350,162,1004,682,55,726,164,248,260,258,259,53,116,835,701,512,609,727,482
g1920,Q9Y263,PLAP_HUMAN,PLAP_HUMAN,Phospholipase A-2-activating protein (PLA2P) (PLAP),PLAA PLAP,cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; macroautophagy [GO:0016236]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; nervous system development [GO:0007399]; phospholipid metabolic process [GO:0006644]; positive regulation of dendrite extension [GO:1903861]; positive regulation of neuron migration [GO:2001224]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of synaptic vesicle recycling [GO:1903423]; prostaglandin metabolic process [GO:0006693]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; signal transduction [GO:0007165]; ubiquitin recycling [GO:0010992]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],GO:0005634; GO:0005737; GO:0006644; GO:0006693; GO:0006954; GO:0007165; GO:0007399; GO:0010992; GO:0016005; GO:0016236; GO:0032430; GO:0043130; GO:0043161; GO:0043162; GO:0045202; GO:0070062; GO:0071222; GO:1900045; GO:1903423; GO:1903861; GO:2001224,1616,1296,1296,931,1331,1280,1198,1392,1752,2464,901,1834,2309,985,891,2066,1419,656,726,930,977,625,658,425,627,530,402,459
g143,Q0IIF7,UBP14_BOVIN,UBP14_BOVIN,Ubiquitin carboxyl-terminal hydrolase 14 (EC 3.4.19.12) (Deubiquitinating enzyme 14) (Ubiquitin thioesterase 14) (Ubiquitin-specific-processing protease 14),USP14,innate immune response [GO:0045087]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; regulation of proteasomal protein catabolic process [GO:0061136],GO:0000502; GO:0004843; GO:0005737; GO:0005886; GO:0016579; GO:0043161; GO:0045087; GO:0061136; GO:0070628,813,526,547,511,921,520,586,602,714,919,244,1136,611,493,839,1347,631,379,404,1273,538,315,408,279,473,235,483,237
g388,O70277,TRIM3_RAT,TRIM3_RAT,Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22),Trim3 Berp Rnf22,negative regulation of translation [GO:0017148]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252],GO:0000209; GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0017148; GO:0030371; GO:0030425; GO:0034141; GO:0042802; GO:0043161; GO:0061630; GO:0070534; GO:0098794; GO:0098978; GO:0140252,330,462,572,208,366,377,552,546,57,48,64,103,73,15,20,44,46,69,61,74,13,33,416,202,217,290,164,238
g387,Q9ESN6,TRIM2_MOUSE,TRIM2_MOUSE,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (Neural activity-related RING finger protein) (RING-type E3 ubiquitin transferase TRIM2),Trim2 Kiaa0517 Narf,cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0017022; GO:0017148; GO:0030371; GO:0043161; GO:0043523; GO:0061630; GO:1990830,22,45,78,63,63,19,56,68,11,5,2,11,11,0,1,3,2,3,4,1,0,11,55,22,14,36,7,38
g12528,Q7SXR3,MAEA_DANRE,MAEA_DANRE,E3 ubiquitin-protein transferase MAEA (EC 2.3.2.27) (Macrophage erythroblast attacher),maea zgc:63708,cell division [GO:0051301]; erythrocyte maturation [GO:0043249]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0003779; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0005886; GO:0016363; GO:0034657; GO:0043161; GO:0043249; GO:0046872; GO:0051301; GO:0061630,770,1063,1118,742,892,1015,882,997,704,744,441,952,870,307,1512,1231,443,442,485,295,442,487,475,297,396,464,318,367
g16612,Q5ZHY5,CHIP_CHICK,CHIP_CHICK,E3 ubiquitin-protein ligase CHIP (EC 2.3.2.27) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1),STUB1 RCJMB04_32b21,cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; positive regulation of proteolysis [GO:0045862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0006281; GO:0006511; GO:0006515; GO:0030018; GO:0034450; GO:0042803; GO:0043161; GO:0045862; GO:0051087; GO:0061630; GO:0071218,351,377,417,328,325,416,387,444,172,53,161,294,107,13,273,58,35,95,81,41,30,22,199,223,124,229,267,281
g6442,Q8VDM4,PSMD2_MOUSE,PSMD2_MOUSE,26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97),Psmd2,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176],GO:0000502; GO:0005634; GO:0005838; GO:0008540; GO:0022624; GO:0030234; GO:0034515; GO:0042176; GO:0043161,5182,3604,3888,2828,5625,3523,3452,3907,6188,7728,4734,5904,7756,3493,3799,6379,5435,2351,2625,4451,3090,2879,2311,1532,2415,1469,2148,1738
g13779,Q5F418,PSMD1_CHICK,PSMD1_CHICK,26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1),PSMD1 RCJMB04_3m24,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176],GO:0005634; GO:0008540; GO:0022624; GO:0030234; GO:0034515; GO:0042176; GO:0043161,2056,1254,1272,979,1912,1197,1028,1453,2692,3349,1071,2665,2734,1129,1228,2412,2862,1140,1325,1525,1474,1223,1140,608,920,509,632,450
g13778,Q5F418,PSMD1_CHICK,PSMD1_CHICK,26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1),PSMD1 RCJMB04_3m24,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176],GO:0005634; GO:0008540; GO:0022624; GO:0030234; GO:0034515; GO:0042176; GO:0043161,475,361,393,241,634,400,304,426,732,1086,392,830,943,300,521,613,744,319,348,321,431,233,292,223,244,196,113,225
g2687,P51665,PSMD7_HUMAN,PSMD7_HUMAN,26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8) (26S proteasome regulatory subunit S12) (Mov34 protein homolog) (Proteasome subunit p40),PSMD7 MOV34L,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0016020; GO:0034774; GO:0042803; GO:0043161; GO:0070062; GO:1904813,2071,1481,1488,961,2157,1361,1153,1971,3966,4485,2034,3235,3007,1735,2657,4140,2952,847,1294,1489,1264,1489,841,714,1123,490,771,452
g15347,Q9QZN1,FXL17_MOUSE,FXL17_MOUSE,F-box/LRR-repeat protein 17 (F-box and leucine-rich repeat protein 17) (F-box only protein 13),Fbxl17 Fbl17 Fbx13 Fbxo13,entrainment of circadian clock by photoperiod [GO:0043153]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of smoothened signaling pathway [GO:0008589]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],GO:0000209; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006515; GO:0007399; GO:0008589; GO:0014033; GO:0016567; GO:0019005; GO:0031146; GO:0043153; GO:0043161,337,410,450,322,411,311,457,512,167,145,168,305,212,29,213,120,78,113,123,161,42,97,284,233,234,222,256,153
g5143,P25788,PSA3_HUMAN,PSA3_HUMAN,Proteasome subunit alpha type-3 (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8) (Proteasome subunit alpha-7) (alpha-7),PSMA3 HC8 PSC8,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of endopeptidase activity [GO:0052548],GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0019773; GO:0031625; GO:0043161; GO:0045202; GO:0052548; GO:0070062,2929,1912,1623,1414,2406,1661,1226,1999,2870,2668,2395,2811,4028,835,4127,2060,1716,1094,1239,1361,583,791,814,880,1018,685,516,567
g9857,P54814,PRS8_MANSE,PRS8_MANSE,26S proteasome regulatory subunit 8 (Protein 18-56),,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],GO:0005524; GO:0005634; GO:0005737; GO:0008540; GO:0016887; GO:0036402; GO:0043161,3586,3241,3035,2404,5135,3950,2934,3255,5415,7878,3954,4317,6613,3194,3031,6155,3534,2216,2083,2610,2701,2160,2085,1455,1920,1254,834,1301
g16413,Q6PJ21,SPSB3_HUMAN,SPSB3_HUMAN,SPRY domain-containing SOCS box protein 3 (SSB-3),SPSB3 C16orf31 SSB3,negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936],GO:0005634; GO:0005829; GO:0010719; GO:0019005; GO:0031466; GO:0043161; GO:0070936; GO:0160049; GO:1990756,359,661,578,216,434,1078,536,638,5367,5773,4262,4501,5209,2521,1560,5992,3925,3477,5170,1236,2848,6648,492,580,243,555,536,482